Seyyedeh Nazanin Amiryaghoubi,
Mirzaagha Babazadeh
Department of Chemistry, Tabriz Branch, Islamic Azad University, Tabriz, Iran;
For correspondence:- Mirzaagha Babazadeh
Email: babazadeh@iaut.ac.ir Tel:+984133396024
Received: 27 April 2015
Accepted: 15 June 2015
Published: 29 July 2015
Citation:
Amiryaghoubi SN, Babazadeh M.
Novel polymeric prodrugs of valproic acid as anti-epilepsy drugs: Synthesis, characterization and in-vitro evaluation. Trop J Pharm Res 2015; 14(7):1183-1189
doi:
10.4314/tjpr.v14i7.9
© 2015 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Abstract
Purpose: To synthesize and evaluate, in-vitro, novel polymeric prodrugs of valproic acid (VPA) for anti-epileptic activity.
Methods: Homopolymer of 4-chloromethyl styrene (CMS) and its copolymers with various acrylic-type monomers such as 2-hydroxyethyl methacrylate and methyl methacrylate were prepared by free radical polymerization method. VPA was then covalently linked to the obtained polymers by treating CMS polymers with sodium valproate. All the compounds were characterized by Fourier transform infrared (FT-IR), nuclear magnetic resonance (1H and 13C-NMR), elemental analyses, and gel permeation chromatography (GPC). The release of VPA from polymeric prodrugs was studied using cellophane membrane dialysis bags containing aqueous buffer solutions (pH 1, 7 and 10) at 37 oC. The quantity of released drug was detected by ultraviolet (UV) spectroscopy.
Results: 1H-NMR and elemental analyses data for calculating mole composition of CMS polymers were relatively in good agreement. FT-IR and NMR data for the polymeric prodrugs showed attachment of drug substituents to phenyl rings of CMS units via methylene spacer. The drug-release profiles indicated that selective hydrolysis of ester bond between the drug and the polymer backbone is strongly dependent on polymer hydrophilicity and the pH of the hydrolysis solution.
Conclusion: The synthesized VPA polymeric prodrugs may be cost-effective compounds for release of VPA in vivo when formulated as controlled release systems.
Keywords: 4-Chloromethyl styrene, Valproic acid, Polymeric prodrugs, Controlled release, Hydrolysis